Siren LLC’s Odyssey Therapeutics ODTX Stock Holding History

Siren LLC’s Portfolio ODTX Stock Details ODTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.44M	Hold	200,000	–	–	0.11%	86
2026 Q2	$3.74M	Buy	+200,000	New	+$3.51M	0.08%	98

Other funds holding ODTX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Lightspeed Management Company Menlo Park, California $2.03B AUM 10.68% 1-Year Est. Return

Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return

Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Siren LLC's ODTX Position: Q3 2026 in Review

Siren LLC held its Odyssey Therapeutics (ODTX) position steady in Q3 2026 at 200,000 shares worth $4.44M. The position accounts for 0.11% of the portfolio, ranked #86.

Siren LLC first reported a position in ODTX in Q2 2026 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold ODTX as of Q3 2026.

Siren LLC held 200,000 shares of Odyssey Therapeutics worth $4.44M as of Q3 2026.
Siren LLC left its Odyssey Therapeutics share count unchanged in Q3 2026.
Odyssey Therapeutics made up 0.11% of Siren LLC's portfolio in Q3 2026, its #86 holding.
Siren LLC first reported a position in Odyssey Therapeutics in Q2 2026 and has held it in 2 quarters since.
41 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q3 2026.

Based on Siren LLC's 13F filing for Q3 2026, filed 12 Nov 2026.